Liraglutide in Newly Onset Type 1 Diabetes.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Liraglutide

DRUG

Placebo

Saline

Trial Locations (1)

2650

Dep. of Endocrinology, Hvidovre University Hospital, Hvidovre

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Hillerod Hospital, Denmark

OTHER

collaborator

Bispebjerg Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

lead

Hvidovre University Hospital

OTHER

NCT01879917 - Liraglutide in Newly Onset Type 1 Diabetes. | Biotech Hunter | Biotech Hunter